Table 1.
Advantages and disadvantages of different gene therapy vectors
| Vector | Advantages | Disadvantages |
|---|---|---|
| Viral vectors | ||
| Adeno-associated Viruses | Low immunogenicity Stable transgene expression |
Small transgene insert capacity (~4.8 kb) Complex process of vector production |
| Adenovirus | Biologically safe Large transgene insert capacity (~38 kb) |
High immunogenicity Short term gene expression |
| Herpes simplex virus | Large transgene insert capacity (~150 kb) | Immunogenicity |
| Lentivirus | Infect both dividing and nondividing cells Long term stable expression of transgene Low immunogenicity |
Insertional mutagenesis |
| Measles Virus | Better safety profile | Wild type virus is immunosuppressive Many adults are immune |
| Retrovirus | Infect only dividing cells Stable transgene expression |
Risk of insertion Small transgene insert capacity Immunogenicity, low efficiency in vivo |
| Vaccinia virus | Large insert capacity Better safety profile |
High immunogenicity Replication in skin lesion |
| Vesicular Stomatitis virus | Selective replication competent in tumor cells | High immunogenicity Animal pathogen-safety concern |
| Non viral vectors | ||
| Plasmid/Naked DNA | Easy to engineer Low immunogenicity |
Rapid clearance, low transfection efficiency |
| Cationic liposomes | Large gene carrying capacity Better accumulation of nanoparticle in tumors |
Low transfection efficacy and inflammatory toxicity |